HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 87 filers reported holding HARVARD BIOSCIENCE INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,682,000 | -7.6% | 431,848 | +4.8% | 0.33% | +0.3% |
| Q4 2021 | $2,904,000 | +9.3% | 411,875 | +8.2% | 0.33% | +2.1% |
| Q3 2021 | $2,658,000 | -16.7% | 380,736 | -0.6% | 0.33% | -12.1% |
| Q2 2021 | $3,192,000 | +94.5% | 383,183 | +27.5% | 0.37% | +85.5% |
| Q1 2021 | $1,641,000 | +15.2% | 300,516 | -9.5% | 0.20% | +13.0% |
| Q4 2020 | $1,425,000 | +20.1% | 332,115 | -15.8% | 0.18% | +4.1% |
| Q3 2020 | $1,187,000 | +54.0% | 394,489 | +58.5% | 0.17% | +34.9% |
| Q2 2020 | $771,000 | +39.4% | 248,836 | -0.5% | 0.13% | +12.5% |
| Q1 2020 | $553,000 | -65.4% | 250,000 | -52.3% | 0.11% | -43.1% |
| Q4 2019 | $1,599,000 | +4.1% | 524,264 | +4.9% | 0.20% | -11.3% |
| Q3 2019 | $1,536,000 | +37.9% | 499,616 | -10.3% | 0.22% | +45.1% |
| Q2 2019 | $1,114,000 | -45.7% | 556,886 | +16.9% | 0.15% | -49.5% |
| Q1 2019 | $2,053,000 | -34.0% | 476,293 | -51.3% | 0.30% | +24.2% |
| Q4 2018 | $3,112,000 | +13.6% | 978,878 | +87.6% | 0.24% | -24.2% |
| Q3 2018 | $2,740,000 | +2.3% | 521,874 | +4.3% | 0.32% | -3.9% |
| Q2 2018 | $2,678,000 | +7.1% | 500,544 | +0.1% | 0.34% | +1.8% |
| Q1 2018 | $2,500,000 | +41.2% | 499,934 | -6.8% | 0.33% | +40.6% |
| Q4 2017 | $1,771,000 | -12.7% | 536,681 | -0.8% | 0.23% | -15.2% |
| Q3 2017 | $2,028,000 | +85.2% | 540,819 | +25.9% | 0.28% | +75.8% |
| Q2 2017 | $1,095,000 | +36.0% | 429,460 | +38.7% | 0.16% | +24.6% |
| Q1 2017 | $805,000 | +10.6% | 309,582 | +29.8% | 0.13% | +5.0% |
| Q4 2016 | $728,000 | +68.9% | 238,530 | +50.5% | 0.12% | +73.9% |
| Q3 2016 | $431,000 | -7.1% | 158,512 | -2.3% | 0.07% | -10.4% |
| Q2 2016 | $464,000 | -6.3% | 162,208 | -1.1% | 0.08% | -9.4% |
| Q1 2016 | $495,000 | -23.1% | 163,995 | -11.6% | 0.08% | -15.8% |
| Q4 2015 | $644,000 | -13.9% | 185,608 | -6.3% | 0.10% | -17.9% |
| Q3 2015 | $748,000 | – | 198,010 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Harvey Partners, LLC | 790,000 | $2,378,000 | 3.09% |
| Alambic Investment Management, L.P. | 25,398 | $76,000 | 0.83% |
| Adirondack Research & Management Inc. | 190,494 | $573,000 | 0.80% |
| Archon Capital Management LLC | 881,794 | $2,654,000 | 0.53% |
| BARD ASSOCIATES INC | 1,483,610 | $4,465,000 | 0.47% |
| DALTON GREINER HARTMAN MAHER & CO | 909,977 | $2,739,000 | 0.45% |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 1,537,800 | $4,629,000 | 0.40% |
| Portolan Capital Management | 979,067 | $2,947,000 | 0.33% |
| HEARTLAND ADVISORS INC | 961,400 | $2,894,000 | 0.25% |
| Granahan Investment Management | 1,757,176 | $5,289,000 | 0.18% |